Kilitch Drugs (India) Shareholding Pattern
- Market cap
- ₹871 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹179.42 – ₹336.41
As of Jun 2026, promoters held 48.50% of Kilitch Drugs (India), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.
Kilitch Drugs (India) shareholding pattern — frequently asked questions
What is the promoter holding in Kilitch Drugs (India)?
Promoters held 48.50% of Kilitch Drugs (India) as of Jun 2026.
How much do FIIs hold in Kilitch Drugs (India)?
Foreign institutional investors held 18.40% of Kilitch Drugs (India) as of Jun 2026.
How much do domestic institutions hold in Kilitch Drugs (India)?
Domestic institutional investors, including mutual funds and insurers, held 14.20% of Kilitch Drugs (India) as of Jun 2026; mutual funds alone held 8.50%.
Who owns Kilitch Drugs (India)?
As of Jun 2026, Kilitch Drugs (India)'s shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.
Same Data For Peers
- Krishna Institute of Medical Sciences Limited shareholding pattern
- Jubilant Pharmova Limited shareholding pattern
- Krsnaa Diagnostics Limited shareholding pattern
- Jupiter Life Line Hospitals Limited shareholding pattern
- Dr. Lal Path Labs Limited. shareholding pattern
- JHS Svendgaard Laboratories Limited shareholding pattern
Trade Kilitch Drugs (India) With ATS
Track KILITCH live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.